Application Nr Approved Date Route Status External Links
NDA208383 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Bevyxxa Is Indicated For The Prophylaxis Of Venous Thromboembolism (Vte) In Adult Patients Hospitalized For An Acute Medical Illness Who Are At Risk For Thromboembolic Complications Due To Moderate Or Severe Restricted Mobility And Other Risk Factors For Vte [See Clinical Studies (14) ] . Bevyxxa Is A Factor Xa (Fxa) Inhibitor Indicated For The Prophylaxis Of Venous Thromboembolism (Vte) In Adult Patients Hospitalized For An Acute Medical Illness Who Are At Risk For Thromboembolic Complications Due To Moderate Or Severe Restricted Mobility And Other Risk Factors For Vte. ( 1 ) Limitations Of Use: Safety And Efficacy Of Bevyxxa Have Not Been Established In Patients With Prosthetic Heart Valves Because This Population Has Not Been Studied. ( 1 ) Limitations Of Use: The Safety And Effectiveness Of Bevyxxa Have Not Been Established In Patients With Prosthetic Heart Valves Because This Population Has Not Been Studied.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Betrixaban BETRIXABAN ZINC30691754

Comments